|
Report Date : |
13.12.2014 |
IDENTIFICATION DETAILS
|
Name : |
BRUKER BIOSPIN AG |
|
|
|
|
Registered Office : |
Industriestrasse 26, 8117 Fällanden/ZH |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2013 |
|
|
|
|
Date of Incorporation : |
24.06.1965 |
|
|
|
|
Com. Reg. No.: |
020.3.924.534-8 / 431763 |
|
|
|
|
Legal Form : |
Company Limited By Shares |
|
|
|
|
Line of Business : |
· Manufacture of instruments and appliances for measuring, testing and navigation · Manufacture of irradiation, electro medical and electrotherapeutic equipment |
|
|
|
|
No of Employees : |
500 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2014
|
Country Name |
Previous Rating (30.06.2014) |
Current Rating (30.09.2014) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Source
: CIA |
BRUKER BIOSPIN AG
Operating
address:
Industriestrasse
26
8117 Fällanden/ZH
Switzerland/CH
Telephone: 044
8259111
Fax: 044
8259696
Web
site: http://www.bruker.com
E-mail: Info.bbio.ch@bruker.com
WIN
Worldbox No.: CH0000444189
VAT-No.: CHE101138357
Established: 1965
Line
of Business: Measurement and
control technology, Medical technology
Industry
Division: Manufacturing
Industry-code (NACE): 2651 Manufacture of instruments and appliances
for measuring, testing and navigation
2660 Manufacture of irradiation, electro
medical and electrotherapeutic equipment
Import/Export: Import, Export
Quality
certification: ISO 9001:2008
Banks: CS Credit Suisse
Coverage: Company
Figures: estimated
Financial
year: 2014
Employees: 500
Sales: CHF 260,000,000.--
The company is engaged in the production and
sale of scientific devices as well as the planning and construction of research
plants and institutes, in particular in the sector of the magnetic resonance.
Real
Estate: The company owns
buildings.
Company
No: 020.3.924.534-8 /
431763
Legal
form: Company limited
by shares
Registration: 24.06.1965
Legal
status: active
Responsible
Register: Handelsregister des Kantons
Zürich
History: Date of Statutes:
10.04.1981
Date of
Statutes: 26.11.2013
Date of
Statutes: 13.02.2008
Date of
Statutes: 20.12.2007
Date of
Statutes: 26.09.2001
Date of
Statutes: 16.06.1998
Date of
Statutes: 21.03.1997
Entry Deleted Name
05.10.2001 Bruker
BioSpin AG
26.06.1998 Spectrospin AG
26.06.1998 05.10.2001 Bruker AG
Entry Deleted Legal domicile
active
Entry Deleted Address
active Industriestrasse
26, 8117
Entry Deleted Capital
active Share
Capital CHF 5,000,000, paidup CHF 5,000,000
Entry Deleted Capital Structure
05.10.2001 50,000
Registered shares of CHF 100.--
Title Name
President Thomas
Bachmann
Citizen:
Residential
address: Zollikon, Switzerland
joint
signature of two
Registered
since: 07.01.2014
Director Dr.
Werner E. Maas
Citizen:
Netherlands
Residential
address: Merrimac /MA, United States of America
joint
signature of two
Registered
since: 08.07.2008
Title Name
Director Dr. René
Jeker
Citizen:
Büsserach, Switzerland
Residential
address: Hombrechtikon, Switzerland
joint
signature of two
Registered
since: 01.10.1997
Director Dr. Rainer
Kümmerle
Citizen:
Germany
Residential
address: 8620 Wetzikon /ZH, Switzerland
joint
signature of two
Registered
since: 17.05.2010
Director Stephan
Westermann
Citizen:
Germany
Residential
address: Bergneustadt , Germany
joint
signature of two
Registered
since: 23.09.2013
Vice-Director Dr. Daniel Eckert
Citizen:
Basel, Switzerland
Residential
address: 8184 Bachenbülach/ZH, Switzerland
joint
signature of two
Registered
since: 17.05.2010
Vice-Director Volker Ilg
Citizen:
Germany
Residential
address: Zollikon, Switzerland
joint
signature of two
Registered
since: 23.09.2013
Vice-Director Pietro Lendi
Citizen:
Uznach, Switzerland
Residential
address: 8730 Uznach/SG, Switzerland
joint
signature of two
Registered
since: 17.05.2010
Vice-Director Remo Lüchinger
Citizen:
Oberriet SG, Switzerland
Residential
address: Zürich, Switzerland
joint
signature of two
Registered
since: 17.05.2010
Member
with signing authority Peter Kistler
Citizen:
Reichenburg, Switzerland
Residential
address: Rapperswil-Jona, Switzerland
joint
signature of two
Registered
since: 07.05.2014
Member
with signing authority Dr. Kurt
Schenker
Citizen:
Däniken, Switzerland
Residential
address: Maur, Switzerland
joint
signature of two
Registered
since: 07.05.2014
Member
with signing authority Dr. Peter
Scherer
Citizen:
Killwangen, Switzerland
Residential
address: Dübendorf, Switzerland
joint
signature of two
Registered
since: 07.05.2014
Member
with signing authority Urs Widmer
Citizen:
Lindau, Switzerland
Residential
address: Neftenbach, Switzerland
joint
signature of two
Registered
since: 07.05.2014
Title Name
Auditor Ernst
& Young AG
Residential
address: Zürich, Switzerland
Id:
CHE-491.907.686
Registered
since: 17.11.2000
Name: Bruker Corporation
City/Country: Billerica/Massachusetts, United
States of America/US
Consolidation: consolidated
Industry: Trade/Industry
Fiscal year end: 31.12.2013 31.12.2012 31.12.2011 31.12.2010 31.12.2009
Number of months: 12 12 12 12 12
Currency: th.
USD th. USD th. USD th. USD th.
USD
Statement norm: US-GAAP US-GAAP
Balance Sheet
Intangible fixed
assets 233,000.0 232,900.0 236,600.0 234,400.0 52,400.0
Other tangible
fixed assets 299,500.0 283,600.0
Tangible fixed
assets 299,500.0 283,600.0 249,000.0 233,700.0 223,400.0
Financial fixed
assets 0.0 0.0 0.0
other fixed assets 23,900.0 30,200.0 30,800.0 30,600.0 22,700.0
Fixed assets 556,400.0 546,700.0 516,400.0 498,700.0 298,500.0
Stocks 589,800.0 611,500.0 576,200.0 511,000.0 422,800.0
Trade accounts
receivable 307,600.0 289,300.0
Liquid assets 438,700.0 310,600.0 246,000.0 230,400.0 207,100.0
other trade
accounts 95,800.0 98,300.0
Other current
assets 534,500.0 408,900.0
Current assets 1,431,900.0 1,309,700.0 1,194,100.0 1,051,100.0 873,500.0
Total assets 1,988,300.0 1,856,400.0 1,710,500.0 1,549,800.0 1,172,000.0
Capital 64,600.0 49,800.0
Other shareholders
funds 781,500.0 656,800.0
Total shareholders equity 846,100.0 706,600.0 621,500.0 524,700.0 417,200.0
Minority interests 4,100.0 3,100.0 3,400.0 2,700.0 1,600.0
long term debt
(financial debts) 388,000.0 370,800.0 215,300.0 81,700.0 109,700.0
Provisions 39,200.0 39,400.0 27,700.0
Other non current
liabilities 101,500.0 94,100.0 75,300.0 69,800.0 75,600.0
Non current
liabilities 489,500.0 464,900.0 329,800.0 190,900.0 213,000.0
short term debt
(financial debts) 700.0 1,300.0
Trade accounts
payable 74,800.0 69,600.0
Accruals 199,600.0 192,800.0
other accounts
payable 373,500.0 418,100.0
other current
liabilities 573,100.0 610,900.0
Current liabilities 648,600.0 681,800.0 755,800.0 831,500.0 540,200.0
Total liabilities 1,988,300.0 1,856,400.0 1,710,500.0 1,549,800.0 1,172,000.0
Profit and loss
account
Net sales 1,830,700.0 1,766,500.0 1,651,700.0 1,304,900.0 1,114,500.0
Other operating
revenue 8,700.0 24,900.0
Operating revenue 1,839,400.0 1,791,400.0
Cost of goods sold 1,034,200.0 962,000.0
Gross profit 805,200.0 829,400.0
Other operating
expenses 657,000.0 673,400.0
Operating result 148,200.0 156,000.0 156,200.0 156,300.0 137,500.0
Interest revenues 1,000.0 900.0
other financial
revenues 900.0 2,500.0
Financial income 1,900.0 3,400.0
Interest expenses 13,400.0 14,300.0
other financial
expenses 12,100.0 6,800.0
Financial expenses 25,500.0 21,100.0
Financial result -23,600.0 -17,700.0
Result before extraordinary items 124,600.0 138,300.0
Extraordinary
Result 0.0 0.0
Result before taxes 124,600.0 138,300.0
Taxes 42,800.0 60,100.0
Result before
minority interests 81,800.0 78,200.0
minority interests 1,700.0 700.0
Result for the financial year 80,100.0 77,500.0 92,300.0 95,400.0 81,200.0
Depreciation 61,300.0 59,100.0
Cash flow 143,100.0 137,300.0
Cash flow from
operating activities 145,000.0 133,100.0
Investments in
tangible fixed assets 50,300.0 72,800.0
Cash flow from
investing activities -60,000.0 -93,200.0
Cash flow from
financing activities 26,500.0 34,400.0
Others 16,600.0 -9,700.0
Change in
liquidity 128,100.0 64,600.0
Liquidity at
beginning of the year 310,600.0 246,000.0
Liquidity at end
ot the year 438,700.0 310,600.0
Material costs 1,034,200.0 962,000.0
Research and
Development 190,500.0 195,300.0
Added value 199,300.0 211,700.0
Working Capital 822,600.0 831,200.0
Sales per Employee 295.3 276.0
Gross cost land
and buildings 336,600.0 305,700.0
Gross cost other
tangible fixed assets 362,600.0 337,300.0
Gross cost total 699,200.0 643,000.0
Full time units at
year end 6,200 6,400
No.
of Owner/-s: 1
Owner: The company is foreign
owned.
Class: 100%
Type: indirect,
Group-Level 1
Name: Bruker Corporation
City/Country: Billerica/Massachusetts, United
States of America/US
Interest: 100,00% voting right,
100,00% capital interest
Class: 100%
Type: direct
Name: Bruker Invest AG
City/Country: Fällanden/ZH, Switzerland/CH
Interest: 100,00% voting right,
100,00% capital interest
Name: Bruker BioSpin
International AG
City/Country: Fällanden/ZH, Switzerland/CH
Investments
It is believed that the company has no
investments.
Control date Year No. Amount CHF Status
04.04.2014 2014 0
31.12.2013 2013 0
31.12.2012 2012 0
31.12.2011 2011 0
31.12.2010 2010 0
31.12.2009 2009 0
An updated legal action check is only available
against proof of interest. e.g. a copy of an enquiry letter, and order or
invoice relating to the subject company.
Debt Collection Case:
SEP 2013: CHF 4'042.00.
Financial
Statements: The company does not
disclose any financial statements. Third parties are not permitted any insight
into the financial affairs. It is therefore difficult to make a proper
assessment of the actual situation.
Financial
Situation: The financial situation
is considered to be good.
Payment
experiences: Payment habits are
considered good.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.44 |
|
|
1 |
Rs.98.15 |
|
Euro |
1 |
Rs.77.38 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.